Prognostic value of receptor activator of nuclear factor kappa-B (RANK) marker in patients with breast cancer
Despite notable progress made in studying breast cancer (BC), the mechanisms of metastases, in view of the classification into molecular subtypes, in patients with BC remain to be fully uninvestigated, in the presence of a good prognosis in particular. To study novel diagnostic and predictive marker...
Main Authors: | S. I. Zabroda, E. A. Maslyukova, L. I. Korytova, G. A. Raskin, K. M. Pozharissky, O. V. Korytov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2015-07-01
|
Series: | Opuholi Ženskoj Reproduktivnoj Sistemy |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/428 |
Similar Items
-
OSTEOPROTEGERIN AS A PREDICTIVE MARKER OF THE COURSE OF BREAST CANCER
by: S. I. Zabroda, et al.
Published: (2015-04-01) -
Expression of the RANK/RANKL/OPG system in the human intervertebral disc: implication for the pathogenesis of intervertebral disc degeneration
by: Tomohiko Sano, et al.
Published: (2019-05-01) -
OPG/RANK/RANKL signaling axis in patients with type I diabetes: Associations with parathormone and vitamin D
by: Paraskevi Karalazou, et al.
Published: (2019-12-01) -
RANK/RANKL/OPG system in the intervertebral disc
by: Norihiko Takegami, et al.
Published: (2017-06-01) -
Expressions of Osteoprotegerin and Receptor Activator of Nuclear Factor Kappa-B Ligand in Alveolar Bone Socket under Low Plasma Estrogen Level Condition
by: Agung Krismariono, et al.
Published: (2017-10-01)